📣 VC round data is live. Check it out!

Nakanishi Valuation Multiples

Discover revenue and EBITDA valuation multiples for Nakanishi and similar public comparables like PROCEPT BioRobotics, Immunocore Holdings, Cofoe Medical, Weigao Group and more.

Nakanishi Overview

About Nakanishi

Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning most of its revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The industrial product segment manufactures and sells grinders for manual works and spindles for machinery attachment. The others segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.


Founded

1981

HQ

Japan

Employees

1.4K

Financials (LTM)

Revenue: $547M
EBITDA: $135M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nakanishi Financials

Nakanishi reported last 12-month revenue of $547M and EBITDA of $135M.

In the same LTM period, Nakanishi generated $312M in gross profit, $135M in EBITDA, and $24M in net income.

Revenue (LTM)


Nakanishi P&L

In the most recent fiscal year, Nakanishi reported revenue of $530M and EBITDA of $130M.

Nakanishi is unprofitable as of last fiscal year, with gross margin of 54%, EBITDA margin of 25%, and net margin of (3%).

See analyst estimates for Nakanishi
LTMLast FY202320242025202620272028
Revenue$547M$530M$374M$483M$509M
Gross Profit$312M$289M$226M$278M$289M
Gross Margin57%54%61%58%57%
EBITDA$135M$130M$202M$123M$58M
EBITDA Margin25%25%54%25%11%
EBIT Margin18%17%24%19%17%
Net Profit$24M($15M)$143M$54M($15M)
Net Margin4%(3%)38%11%(3%)

Financial data powered by Morningstar, Inc.

Nakanishi Stock Performance

Nakanishi has current market cap of $2B, and enterprise value of $1B.

Market Cap Evolution


Nakanishi's stock price is $18.24.

Nakanishi share price decreased by 4.7% in the last 30 days, and increased by 52.9% in the last year.

Nakanishi has an EPS (earnings per share) of $-0.18.

See more trading valuation data for Nakanishi
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$2B-4.8%-4.7%7.2%52.9%$-0.18

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nakanishi Valuation Multiples

Nakanishi trades at 2.4x EV/Revenue multiple, and 9.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Nakanishi

EV / Revenue (LTM)


Nakanishi Financial Valuation Multiples

As of June 4, 2026, Nakanishi has market cap of $2B and EV of $1B.

Nakanishi has a P/E ratio of 63.9x.

LTMLast FY202320242025202620272028
EV/Revenue2.4x2.5x3.6x2.8x2.6x
EV/EBITDA9.9x10.3x6.6x10.9x23.0x
EV/EBIT13.6x14.6x15.0x14.7x15.2x
EV/Gross Profit4.3x4.6x5.9x4.8x4.6x
P/E63.9x(100.8x)10.6x28.2x(100.8x)
EV/FCF33.1x18.9x82.4x21.3x18.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nakanishi Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nakanishi Margins & Growth Rates

Nakanishi grew revenue by 8% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Nakanishi reported gross margin of 54%, EBITDA margin of 25%, and net margin of (3%).

See estimated margins and future growth rates for Nakanishi

Nakanishi Margins

Last FY202420252026202720282029
Gross Margin54%58%57%57%
EBITDA Margin25%25%11%25%
EBIT Margin17%19%17%19%
Net Margin(3%)11%(3%)14%
FCF Margin13%13%14%3%

Nakanishi Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%29%5%12%
Gross Profit Growth13%23%4%13%
EBITDA Growth9%(39%)(53%)143%
EBIT Growth17%2%(3%)22%
Net Profit Growth(617%)(62%)(128%)(617%)
FCF Growth(79%)287%13%(79%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Nakanishi Operational KPIs

Nakanishi's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Nakanishi's Rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nakanishi's Rule of X is 55% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Nakanishi
LTMLast FY202320242025202620272028
Rule of 4031%37%---
Bessemer Rule of X42%55%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
Opex to Revenue-38%37%39%39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nakanishi Competitors

Nakanishi competitors include PROCEPT BioRobotics, Immunocore Holdings, Cofoe Medical, Weigao Group, El.En. Group, Savaria, Haier Biomedical, BoneSupport, SKAN Group and Anbio Biotechnology.

Most Nakanishi public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
PROCEPT BioRobotics4.4x3.9x(27.0x)(34.2x)
Immunocore Holdings2.7x2.6x(298.4x)(47.1x)
Cofoe Medical2.6x2.4x13.9x13.1x
Weigao Group5.6x5.3x16.1x16.6x
El.En. Group1.8x1.8x11.9x11.4x
Savaria2.4x2.3x11.6x11.2x
Haier Biomedical3.6x3.5x21.3x21.2x
BoneSupport11.9x10.7x57.4x44.0x

This data is available for Pro users. Sign up to see all Nakanishi competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nakanishi

When was Nakanishi founded?Nakanishi was founded in 1981.
Where is Nakanishi headquartered?Nakanishi is headquartered in Japan.
How many employees does Nakanishi have?As of today, Nakanishi has over 1K employees.
Who is the CEO of Nakanishi?Nakanishi's CEO is Eiichi Nakanishi.
Is Nakanishi publicly listed?Yes, Nakanishi is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Nakanishi?Nakanishi trades under 7716 ticker.
When did Nakanishi go public?Nakanishi went public in 2013.
Who are competitors of Nakanishi?Nakanishi main competitors include PROCEPT BioRobotics, Immunocore Holdings, Cofoe Medical, Weigao Group, El.En. Group, Savaria, Haier Biomedical, BoneSupport, SKAN Group, Anbio Biotechnology.
What is the current market cap of Nakanishi?Nakanishi's current market cap is $2B.
What is the current revenue of Nakanishi?Nakanishi's last 12 months revenue is $547M.
What is the current revenue growth of Nakanishi?Nakanishi revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Nakanishi?Current revenue multiple of Nakanishi is 2.4x.
What is the current EBITDA of Nakanishi?Nakanishi's last 12 months EBITDA is $135M.
What is Nakanishi's EBITDA margin?Nakanishi's last 12 months EBITDA margin is 25%.
What is the current EV/EBITDA multiple of Nakanishi?Current EBITDA multiple of Nakanishi is 9.9x.
What is the current FCF of Nakanishi?Nakanishi's last 12 months FCF is $40M.
What is Nakanishi's FCF margin?Nakanishi's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Nakanishi?Current FCF multiple of Nakanishi is 33.1x.
How many companies Nakanishi has acquired to date?Nakanishi hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Nakanishi has invested to date?Nakanishi hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nakanishi

Lists including Nakanishi

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial